eXoZymes, Inc
Price
FilingsNewest: 8-K, Other eventsSep 18 →InsidersNo open-market buys. 1 insider sold $15,427, 0 of 2 sales on a 10b5-1 plan.→HoldersVanguard 0.6%Davidson Kahn 0.3%Geode 0.3%→Financing →
From the filings
Figures
- Net income
- −$10.2Mlast 12 months
- Operating cash flow
- −$6.9Mlast 12 months
- Cash and equivalents
- $5.7Mat the last balance sheet
- Shares outstanding
- 9.3M shareson issue